|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"ann lii cheng"
Showing items 616-625 of 690 (69 Page(s) Totally)
<< < 57 58 59 60 61 62 63 64 65 66 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T08:30:56Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, S.-H. and Cheng, A.-L. and Lin, C.-W. and Hsu, C.-H. and Wu, M.-S. and Yeh, K.-H. and Tzeng, Y.-S. and Chen, L.-T.; CHIH-HUNG HSU; Sung-Hsin Kuo; CHUNG-WU LIN; KUN-HUEI YEH; MING-SHIANG WU; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:12Z |
Recent advances in the treatment of metastatic colorectal cancer in Taiwan
|
Lin, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH; YU-LIN LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:21:44Z |
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
|
Lin, C.-H. and Lien, H.-C. and Hu, F.-C. and Lu, Y.-S. and Kuo, S.-H. and Wu, L.-C. and You, S.-L. and Cheng, A.-L. and Chang, K.-J. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHING-HUNG LIN; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:06:38Z |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yen, R.-F. and Lin, C.-W. and Chen, L.-T. and Tien, H.F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; RUOH-FANG YEN; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:37Z |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells
|
Weng, Y.-I.;Hsu, P.-Y.;Liyanarachchi, S.;Liu, J.;Deatherage, D.E.;Huang, Y.-W.;Zuo, T.;Rodriguez, B.;Lin, C.-H.;Cheng, A.-L.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
Showing items 616-625 of 690 (69 Page(s) Totally)
<< < 57 58 59 60 61 62 63 64 65 66 > >>
View [10|25|50] records per page
|
